Literature DB >> 18007124

Epileptic seizures in clinically diagnosed Alzheimer's disease: report from a geriatric medicine population.

Caroline Hommet, Raphaelle Hureaux, Jean Barré, Thierry Constans, Gilles Berrut.   

Abstract

A diagnosis of Alzheimer's disease (AD) is associated with an increased risk of unprovoked seizures. In this observational study, we analyzed first seizures in a sample of elderly subjects with AD hospitalized in an acute geriatric care unit. Only 2.5% of the hospitalized AD patients were admitted for a first seizure. The seizures are not necessarily symptomatic of AD. Symptomatic cause must be ruled out in order to classify the syndrome before introducing antiepileptic drugs (AEDs). In practice, only recurrent unprovoked seizures or symptomatic location- related epilepsy with a high risk of recurrence should be treated with AEDs.

Entities:  

Mesh:

Year:  2007        PMID: 18007124     DOI: 10.1007/bf03324726

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  5 in total

Review 1.  The efficacy and safety of newer anticonvulsants in patients with dementia.

Authors:  Christian R Dolder; Kimberly L Nealy
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

Review 2.  Epileptic seizures in AD patients.

Authors:  A J Larner
Journal:  Neuromolecular Med       Date:  2009-06-26       Impact factor: 3.843

Review 3.  Electroencephalogram and Alzheimer's disease: clinical and research approaches.

Authors:  Anthoula Tsolaki; Dimitrios Kazis; Ioannis Kompatsiaris; Vasiliki Kosmidou; Magda Tsolaki
Journal:  Int J Alzheimers Dis       Date:  2014-04-24

4.  Epilepsy in patients with Alzheimer's disease: A systematic review.

Authors:  Diane da Costa Miranda; Sonia Maria Dozzi Brucki
Journal:  Dement Neuropsychol       Date:  2014 Jan-Mar

5.  Analysis of Shared Genetic Regulatory Networks for Alzheimer's Disease and Epilepsy.

Authors:  Xiao-Dan Wang; Shuai Liu; Hui Lu; Yalin Guan; Hao Wu; Yong Ji
Journal:  Biomed Res Int       Date:  2021-10-14       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.